These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 22290942

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis.
    Pantel A, Petrella S, Matrat S, Brossier F, Bastian S, Reitter D, Jarlier V, Mayer C, Aubry A.
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4524-9. PubMed ID: 21768507
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations.
    Malik S, Willby M, Sikes D, Tsodikov OV, Posey JE.
    PLoS One; 2012 Oct; 7(6):e39754. PubMed ID: 22761889
    [Abstract] [Full Text] [Related]

  • 6. Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.
    Zhu C, Zhang Y, Shen Y, Siu GK, Wu W, Qian X, Deng G, Xu Y, Lau R, Fan X, Zhang W, Lu H, Yam WC.
    Diagn Microbiol Infect Dis; 2012 Jul; 73(3):260-3. PubMed ID: 22560167
    [Abstract] [Full Text] [Related]

  • 7. Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosis on quinolone resistance.
    Kim H, Nakajima C, Yokoyama K, Rahim Z, Kim YU, Oguri H, Suzuki Y.
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3661-7. PubMed ID: 21646485
    [Abstract] [Full Text] [Related]

  • 8. Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin.
    Nosova EY, Bukatina AA, Isaeva YD, Makarova MV, Galkina KY, Moroz AM.
    J Med Microbiol; 2013 Jan; 62(Pt 1):108-113. PubMed ID: 23019190
    [Abstract] [Full Text] [Related]

  • 9. Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
    Disratthakit A, Prammananan T, Tribuddharat C, Thaipisuttikul I, Doi N, Leechawengwongs M, Chaiprasert A.
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5189-97. PubMed ID: 27297489
    [Abstract] [Full Text] [Related]

  • 10. Double mutation in DNA gyrase confers moxifloxacin resistance and decreased fitness of Mycobacterium smegmatis.
    Luo T, Yuan J, Peng X, Yang G, Mi Y, Sun C, Wang C, Zhang C, Bao L.
    J Antimicrob Chemother; 2017 Jul 01; 72(7):1893-1900. PubMed ID: 28387828
    [Abstract] [Full Text] [Related]

  • 11. Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB.
    Von Groll A, Martin A, Jureen P, Hoffner S, Vandamme P, Portaels F, Palomino JC, da Silva PA.
    Antimicrob Agents Chemother; 2009 Oct 01; 53(10):4498-500. PubMed ID: 19687244
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin.
    Singh P, Jain A, Dixit P, Prakash S, Jaiswal I, Venkatesh V, Singh M.
    J Antibiot (Tokyo); 2015 Jan 01; 68(1):63-6. PubMed ID: 25052485
    [Abstract] [Full Text] [Related]

  • 13. Functional Characterization of the DNA Gyrases in Fluoroquinolone-Resistant Mutants of Francisella novicida.
    Caspar Y, Siebert C, Sutera V, Villers C, Aubry A, Mayer C, Maurin M, Renesto P.
    Antimicrob Agents Chemother; 2017 Apr 01; 61(4):. PubMed ID: 28167561
    [Abstract] [Full Text] [Related]

  • 14. Role of DNA gyrase and topoisomerase IV mutations in fluoroquinolone resistance of Capnocytophaga spp. clinical isolates and laboratory mutants.
    Ehrmann E, Jolivet-Gougeon A, Bonnaure-Mallet M, Fosse T.
    J Antimicrob Chemother; 2017 Aug 01; 72(8):2208-2212. PubMed ID: 28453633
    [Abstract] [Full Text] [Related]

  • 15. Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosis.
    Bernard C, Veziris N, Brossier F, Sougakoff W, Jarlier V, Robert J, Aubry A.
    Antimicrob Agents Chemother; 2015 Mar 01; 59(3):1519-24. PubMed ID: 25534742
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impact of amino acid substitutions in B subunit of DNA gyrase in Mycobacterium leprae on fluoroquinolone resistance.
    Yokoyama K, Kim H, Mukai T, Matsuoka M, Nakajima C, Suzuki Y.
    PLoS Negl Trop Dis; 2012 Mar 01; 6(10):e1838. PubMed ID: 23071850
    [Abstract] [Full Text] [Related]

  • 18. Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam.
    Duong DA, Nguyen TH, Nguyen TN, Dai VH, Dang TM, Vo SK, Do DA, Nguyen VV, Nguyen HD, Dinh NS, Farrar J, Caws M.
    Antimicrob Agents Chemother; 2009 Nov 01; 53(11):4835-9. PubMed ID: 19721073
    [Abstract] [Full Text] [Related]

  • 19. High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility.
    Devasia R, Blackman A, Eden S, Li H, Maruri F, Shintani A, Alexander C, Kaiga A, Stratton CW, Warkentin J, Tang YW, Sterling TR.
    J Clin Microbiol; 2012 Apr 01; 50(4):1390-6. PubMed ID: 22189117
    [Abstract] [Full Text] [Related]

  • 20. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure.
    Wang JY, Lee LN, Lai HC, Wang SK, Jan IS, Yu CJ, Hsueh PR, Yang PC.
    J Antimicrob Chemother; 2007 May 01; 59(5):860-5. PubMed ID: 17412727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.